The second bidding day saw the IPO issue of Pune-based Emcure Pharmaceuticals continue to attract investor interest, with the total subscription amount reaching 4.98 times. So, because the issue is available till today, below are the specifics regarding the offer to help you make an investing decision.
The IPO will be open till July 5 and will include ₹800 Crore in fresh equity offering as well as an OFS of 1.14 crore shares by promoters and other shareholders. Shark Tank’s Namita Thapar will sell her share in the OFS. At the upper end of the price range, the business hopes to raise ₹1,952 Crore.
The IPO is priced between Rs 960 and Rs 1008 a share, with buyers able to bid for 14 shares per lot.
Following the issuance, the promoters’ stake in the company will be decreased to 78.24%.
The company is a leading Indian pharmaceutical company that develops, manufactures, and markets a diverse range of pharmaceutical products across many primary therapeutic areas. It is an R&D-focused company with a distinct product range that comprises orals, injectables, and biotherapeutics.
Non-institutional investors subscribed 13.67 times the quota, while retail investors subscribed 3.43 times. The Qualified Institutional Buyers (QIBs) group had a 100% subscription rate. Employees have subscribed 4.83 times.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
